Burnham & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Burnham & Co's NVS Position: Q3 2026 in Review
Burnham & Co held its Novartis (NVS) position steady in Q3 2026 at 200 shares worth $28.5K. The position accounts for 0.02% of the portfolio, ranked #144.
Burnham & Co first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $31.3K in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Burnham & Co held 200 shares of Novartis worth $28.5K as of Q3 2026.
- Burnham & Co left its Novartis share count unchanged in Q3 2026.
- Novartis made up 0.02% of Burnham & Co's portfolio in Q3 2026, its #144 holding.
- Burnham & Co first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
- Burnham & Co's Novartis position peaked at $31.3K in Q2 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Burnham & Co's 13F filing for Q3 2026, filed 12 Nov 2026.